Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
278
NCT02973360
Dose-Finding Study of SC411 in Children With Sickle Cell Disease
Phase: Phase 2
Role: Lead Sponsor
Start: Mar 2, 2017
Completion: Jan 2, 2022
NCT02604368
A Sickle CEll Disease ComplicatioN Trial
Phase: Phase 3
Start: Mar 31, 2019
Completion: Dec 31, 2020